GlassScriptPhysician profile
Marc A Chalaby
NPI 1487648291
$30,956.11
in general payments reported to CMS, 2019-2025
44 companies · $3,650 in 2025
The $3,650 reported for 2025 was more than what 85% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $312 · 2021: $1,760 · 2022: $8,695 · 2023: $3,203 · 2024: $2,028 · 2025: $3,650.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,106 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,542 · Education: $233.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,106.03 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,542.00 |
| Education | $232.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $10,551.63 | 2019-2025 | |
| Actelion Pharmaceuticals US, INC. | $5,997.37 | 2019-2025 | Uptravi, Opsumit, Opsynvi |
| Genentech USA, INC. | $3,487.78 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $1,798.12 | 2019-2025 | Fasenra, Tezspire, Breztri |
| Glaxosmithkline, LLC. | $1,709.31 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,141.46 | 2019-2025 | Ofev, Spiriva Respimat, Jascayd |
| United Therapeutics Corporation | $856.10 | 2019-2025 | Tyvaso, Tyvaso, Orenitram |
| Tactile Systems Technology INC | $566.77 | 2022-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Genzyme Corporation | $543.90 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $500.34 | 2019-2025 | Dupixent |
| Merck Sharp & Dohme LLC | $481.01 | 2019-2025 | Winrevair |
| Insmed, INC. | $355.23 | 2023-2025 | Arikayce, Brinsupri |
| Abbvie INC. | $310.28 | 2022-2025 | Avycaz, Teflaro |
| Janssen Pharmaceuticals, INC | $303.01 | 2021-2023 | Xarelto |
| Philips North America LLC | $270.66 | 2019-2025 | Vest Therapy Und, (8874) Incourage, (Ak6) Vest Therapy |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $171.11 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Baxter Healthcare | $139.34 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Monarch Airway Clearance System, Hillrom - Life 2000 Ventilation System |
| Grifols USA, LLC | $134.62 | 2019-2025 | Prolastin-C Liquid |
| Intuitive Surgical, INC. | $130.80 | 2025 | |
| Novartis Pharmaceuticals Corporation | $123.31 | 2019-2020 | |
| Boston Scientific Corporation | $118.96 | 2021-2023 | Exalt Model D |
| Electromed, INC. | $114.89 | 2019-2025 | Smartvest |
| Gilead Sciences, INC. | $111.43 | 2019-2024 | |
| Mylan Specialty L.P. | $106.02 | 2021-2024 | Yupelri |
| Fisher & Paykel Healthcare INC | $99.57 | 2023-2024 | Fisher & Paykel Healthcare |
| Medtronic, INC. | $94.92 | 2025 | Vitalflow Console |
| Verona Pharma, INC. | $91.52 | 2025 | Ohtuvayre |
| Jazz Pharmaceuticals INC. | $83.36 | 2024-2025 | |
| Pulmonx Corporation | $72.25 | 2023-2024 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
| Inogen, INC. | $69.43 | 2025 | |
| Mallinckrodt Hospital Products INC. | $69.02 | 2025 | Acthar |
| Inspire Medical Systems, INC. | $50.16 | 2024-2025 | Inspire |
| Amgen INC. | $46.50 | 2022-2025 | Tezspire |
| Pfizer INC. | $34.48 | 2022-2025 | |
| Paratek Pharmaceuticals, INC. | $32.04 | 2021-2022 | |
| Viatris Specialty LLC | $30.75 | 2025 | Yupelri |
| Chiesi USA, INC. | $28.23 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $26.81 | 2021 | |
| Resmed Corp | $25.39 | 2023 | |
| Mallinckrodt Enterprises LLC | $18.22 | 2019 | |
| Portola Pharmaceuticals, LLC | $17.04 | 2019 | |
| Shire North American Group INC | $15.64 | 2019 | |
| Apria Healthcare LLC | $14.38 | 2021 | |
| Csl Behring | $12.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Chalaby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.